Additionally, 1H-MRS has unique sensitivity to 2-hydroxyglutarate (2-HG), a metabolite elevated exclusively in tumor cells with the oncogenic isocitrate dehydrogenase (IDH1) mutation [101,102], frequently found in gliomas [103] and secondary glioblastomas [104]. Here, IDH3A is linked to central nervous system cancer.